A novel proteomics approach to epigenetic profiling of circulating nucleosomes
Authors:
Open Access
- 31 March 2021
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 11 (1) , 1-12
Abstract
Alteration of epigenetic modifications plays an important role in human cancer. Notably, the dysregulation of histone post-translational modifications (PTMs) has been associated with several cancers including colorectal cancer (CRC). However, the signature of histone PTMs on circulating nucleosomes is still not well described. We have developed a fast and robust enrichment method to isolate circulating nucleosomes from plasma for further downstream proteomic analysis. This method enabled us to quantify the global alterations of histone PTMs from 9 CRC patients and 9 healthy donors. Among 54 histone proteoforms identified and quantified in plasma samples, 13 histone PTMs were distinctive in CRC. Notably, methylation of histone H3K9 and H3K27, acetylation of histone H3 and citrullination of histone H2A1R3 were upregulated in plasma of CRC patients. A comparative analysis of paired samples identified 3 common histone PTMs in plasma and tumor tissue including the methylation and acetylation state of lysine 27 of histone H3. Moreover, we highlight for the first time that histone H2A1R3 citrulline is a modification upregulated in CRC patients. This new method presented herein allows the detection and quantification of histone variants and histone PTMs from circulating nucleosomes in plasma samples and could be used for biomarker discovery of cancer.Keywords
This publication has 39 references indexed in Scilit:
- The Clinical Utilization of Circulating Cell Free DNA (CCFDNA) in Blood of Cancer PatientsInternational Journal of Molecular Sciences, 2013
- Epigenetics and Colorectal Cancer PathogenesisCancers, 2013
- Asymmetrically Modified NucleosomesCell, 2012
- Cell-free nucleic acids as biomarkers in cancer patientsNature Reviews Cancer, 2011
- Histone onco-modificationsOncogene, 2011
- Regulation of chromatin by histone modificationsCell Research, 2011
- Global Levels of Histone Modifications Predict Prognosis in Different CancersThe American Journal of Pathology, 2009
- Increased PADI4 expression in blood and tissues of patients with malignant tumorsBMC Cancer, 2009
- Analysis of Histone Modifications by Mass SpectrometryCurrent Protocols in Protein Science, 2008
- Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancerNature Genetics, 2005